RhumbLine Advisers’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-7,246
| Closed | -$40.6K | – | 4373 |
|
2024
Q2 | $40.6K | Sell |
7,246
-9,920
| -58% | -$55.6K | ﹤0.01% | 3735 |
|
2024
Q1 | $89.9K | Sell |
17,166
-175
| -1% | -$917 | ﹤0.01% | 3471 |
|
2023
Q4 | $90.7K | Buy |
17,341
+209
| +1% | +$1.09K | ﹤0.01% | 3483 |
|
2023
Q3 | $270K | Sell |
17,132
-31
| -0.2% | -$489 | ﹤0.01% | 2983 |
|
2023
Q2 | $334K | Sell |
17,163
-14,525
| -46% | -$282K | ﹤0.01% | 2948 |
|
2023
Q1 | $899K | Buy |
31,688
+1,561
| +5% | +$44.3K | ﹤0.01% | 2171 |
|
2022
Q4 | $881K | Sell |
30,127
-724
| -2% | -$21.2K | ﹤0.01% | 2201 |
|
2022
Q3 | $815K | Buy |
30,851
+69
| +0.2% | +$1.82K | ﹤0.01% | 2253 |
|
2022
Q2 | $1.37M | Sell |
30,782
-2,245
| -7% | -$99.8K | ﹤0.01% | 1969 |
|
2022
Q1 | $1.64M | Buy |
33,027
+885
| +3% | +$43.8K | ﹤0.01% | 1913 |
|
2021
Q4 | $1.64M | Sell |
32,142
-969
| -3% | -$49.4K | ﹤0.01% | 1985 |
|
2021
Q3 | $1.85M | Sell |
33,111
-4,270
| -11% | -$238K | ﹤0.01% | 1954 |
|
2021
Q2 | $1.6M | Buy |
37,381
+933
| +3% | +$39.9K | ﹤0.01% | 2050 |
|
2021
Q1 | $1.52M | Buy |
36,448
+1,422
| +4% | +$59.3K | ﹤0.01% | 2023 |
|
2020
Q4 | $1.63M | Buy |
35,026
+125
| +0.4% | +$5.82K | ﹤0.01% | 1940 |
|
2020
Q3 | $1.48M | Buy |
34,901
+506
| +1% | +$21.5K | ﹤0.01% | 1835 |
|
2020
Q2 | $1.65M | Sell |
34,395
-1,010
| -3% | -$48.5K | ﹤0.01% | 1836 |
|
2020
Q1 | $1.63M | Buy |
35,405
+1,602
| +5% | +$73.7K | ﹤0.01% | 1650 |
|
2019
Q4 | $2.03M | Buy |
33,803
+1,516
| +5% | +$91.1K | ﹤0.01% | 1786 |
|
2019
Q3 | $1.83M | Sell |
32,287
-954
| -3% | -$54K | ﹤0.01% | 1793 |
|
2019
Q2 | $1.85M | Buy |
33,241
+1,261
| +4% | +$70.2K | ﹤0.01% | 1788 |
|
2019
Q1 | $1.62M | Sell |
31,980
-2,125
| -6% | -$107K | ﹤0.01% | 1826 |
|
2018
Q4 | $1.37M | Buy |
34,105
+7,637
| +29% | +$308K | ﹤0.01% | 1860 |
|
2018
Q3 | $1.84M | Buy |
26,468
+2,041
| +8% | +$142K | ﹤0.01% | 1706 |
|
2018
Q2 | $1.85M | Buy |
24,427
+4,498
| +23% | +$340K | ﹤0.01% | 1715 |
|
2018
Q1 | $1.05M | Buy |
19,929
+428
| +2% | +$22.6K | ﹤0.01% | 1919 |
|
2017
Q4 | $1.04M | Buy |
19,501
+2,425
| +14% | +$130K | ﹤0.01% | 1925 |
|
2017
Q3 | $1.02M | Buy |
17,076
+1,080
| +7% | +$64.4K | ﹤0.01% | 1966 |
|
2017
Q2 | $1.26M | Sell |
15,996
-1,092
| -6% | -$86.2K | ﹤0.01% | 1829 |
|
2017
Q1 | $1.42M | Buy |
17,088
+4,648
| +37% | +$385K | ﹤0.01% | 1746 |
|
2016
Q4 | $987K | Buy |
12,440
+727
| +6% | +$57.7K | ﹤0.01% | 1858 |
|
2016
Q3 | $820K | Buy |
11,713
+2,418
| +26% | +$169K | ﹤0.01% | 1930 |
|
2016
Q2 | $361K | Buy |
9,295
+297
| +3% | +$11.5K | ﹤0.01% | 2408 |
|
2016
Q1 | $364K | Sell |
8,998
-20
| -0.2% | -$809 | ﹤0.01% | 2424 |
|
2015
Q4 | $800K | Buy |
9,018
+1,095
| +14% | +$97.1K | ﹤0.01% | 1946 |
|
2015
Q3 | $587K | Buy |
7,923
+368
| +5% | +$27.3K | ﹤0.01% | 2119 |
|
2015
Q2 | $611K | Buy |
+7,555
| New | +$611K | ﹤0.01% | 2204 |
|